Akèy › Ensifizyans kadyak › Kansas › Kansas City
Etid klinik pou Ensifizyans kadyak nan Kansas City, KS
13 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
ELEVATE-HFpEF Clinical Study
Ap rekrite
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Ap rekriteFaz 3
- University of Kansas Medical Center, Kansas City
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Ap rekriteFaz 3
- Research Site, Leavenworth · 21 mi lwen
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Ap rekriteFaz 3
- The University of Kansas Medical Center, Kansas City
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Ap rekriteFaz 3
- University of Kansas Medical Center, Kansas City
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Ap rekriteFaz 3
- Kansas City, KS Investigative Site 10060, Kansas City
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Ap rekrite
- The University Of Kansas Medical Center, Kansas City
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Ap rekriteEtid obsèvasyon
- Kansas City, Kansas City
Assessment of CCM in HF With Higher Ejection Fraction
Ap rekrite
- University of Kansas Medical Center, Kansas City
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Ap rekrite
- University of Kansas Medical Center (KUMC), Kansas City
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Ap rekrite
- Kansas University Medical Center, Kansas City
CCM OPEN HF Registry
Ap rekriteEtid obsèvasyon
- University of Kansas Medical Center, Kansas City
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Ap rekriteEtid obsèvasyon
- University of Kansas Medical Center, Kansas City
Etid Ensifizyans kadyak nan lòt vil
- New York City, NY51 etid
- Boston, MA44 etid
- Dallas, TX42 etid
- Houston, TX36 etid
- Cleveland, OH33 etid
- Chicago, IL31 etid
- Philadelphia, PA31 etid
- San Francisco, CA29 etid
- Durham, NC26 etid
- St. Louis, MO26 etid
- Atlanta, GA25 etid
- Kansas City, MO25 etid
Lòt etid nan Kansas City
- Maladi kadyovaskilè14 etid
- Obèsite13 etid
- Maladi poumon entèstisyèl13 etid
- Fibroz sistik13 etid
- Kansè nan tete12 etid
- Kansè vejik12 etid
- Leksemi mieloïd egi12 etid
- Kansè pwostat12 etid
- Kansè Poumon ki pa ti selil11 etid
- Kansè poumon11 etid
- BPCO9 etid
- Asm8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.